Revaprazan (trade name Revanex) is a drug that reduces gastric acid secretion which is used for the treatment of gastritis.

[2] It acts as an acid pump antagonist[3] (potassium-competitive acid blocker).

Revaprazan is approved for use in South Korea,[4] but is not approved in Europe or the United States.

This drug article relating to the gastrointestinal system is a stub.

You can help Wikipedia by expanding it.